Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray
Khan, S.; Nakajima, R.; Jain, A.; de Assis, R. R.; Jasinskas, A.; Obiero, J. M.; Adenaiye, O.; Tai, S.; Hong, F.; Milton, D. K.; Davies, H.; Felgner, P. L.; Prometheus Study Group,
Show abstract
The current practice for diagnosis of SARS-CoV-2 infection relies on PCR testing of nasopharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic risk. This testing strategy likely underestimates the true prevalence of infection, creating the need for serologic methods to detect infections missed by the limited testing to date. Here, we describe the development of a coronavirus antigen microarray containing immunologically significant antigens from SARS-CoV-2, in addition to SARS-CoV, MERS-CoV, common human coronavirus strains, and other common respiratory viruses. A preliminary study of human sera collected prior to the SARS-CoV-2 pandemic demonstrates overall high IgG reactivity to common human coronaviruses and low IgG reactivity to epidemic coronaviruses including SARS-CoV-2, with some cross-reactivity of conserved antigenic domains including S2 domain of spike protein and nucleocapsid protein. This array can be used to answer outstanding questions regarding SARS-CoV-2 infection, including whether baseline serology for other coronaviruses impacts disease course, how the antibody response to infection develops over time, and what antigens would be optimal for vaccine development.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform 95%
- A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects 94%
- Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals 94%
Similar papers in this journal
- SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali 95%
- SARS-CoV-2 Serosurveys: How antigen, isotype and threshold choices affect the outcome 93%
- A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2 93%
Similar papers in this journal
- Distinct SARS-CoV-2 Antibody Reactivity Patterns in Coronavirus Convalescent Plasma Revealed by a Coronavirus Antigen Microarray 95%
- Are commercial antibody assays substantially underestimating SARS-CoV-2 ever infection? An analysis on a population-based sample in a high exposure setting 94%
- Detection of neutralizing antibodies against SARS-CoV-2 by using a commercial surrogate virus neutralization ELISA: can it substitute the classical neutralization test? 93%
Similar papers in this journal
- Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 93%
- Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021—June 2022 93%
- A rapid and flexible microneutralization assay for serological assessment of influenza viruses 92%
Similar papers in this journal
- Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department 94%
- Performance of three SARS-CoV-2 immunoassays, three rapid lateral flow tests and a novel bead-based affinity surrogate test for the detection of SARS-CoV-2 antibodies in human serum 94%
- Clinical evaluation of the Abbott Alinity SARS-CoV-2 spike-specific quantitative IgG and IgM assays in infected, recovered, and vaccinated groups 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.